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Objective: The present study was conducted to assess the effectiveness of yoga in the
management of dyslipidemia in patients of type 2 diabetes mellitus.
Methods: This randomized parallel study was carried out in Medical College Trivandrum,
Kerala, India. Hundred type 2 diabetics with dyslipidemia were randomized into control
and yoga groups. The control group was prescribed oral hypoglycemic drugs. The yoga
group practiced yoga daily for 1 h duration along with oral hypoglycemic drugs for 3
months. The lipid profiles of both the groups were compared at the start and at the end of 3
months.
Results: After intervention with yoga for a period of 3 months the study group showed a
decrease in total cholesterol, triglycerides and LDL, with an improvement in HDL.
Conclusion: Yoga, being a lifestyle incorporating exercise and stress management training,
targets the elevated lipid levels in patients with diabetes through integrated approaches.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction therapeutic value. However, there is no consensus on the idealThe major risk factor for cardiovascular disease in diabetes
mellitus is dyslipidemia.1 The characteristic features of dia-
betic dyslipidemia are a high plasma triglyceride concentra-
tion, low high-density lipoprotein (HDL) concentration and
increased concentration of small dense low-density lipopro-
tein (LDL) particles. Insulin resistance leads to increased flux
of free fatty acids and hence the lipid changes.2 Reports from
the National Health and Nutrition Examination Survey
(NHANES) 1999e2000 indicate that 55% of the U.S. general
population and 51% of adults aged 20e59 years with diabetes
have hypercholesterolemia.3,4
Caloric restriction and weight loss for the overweight
individual with diabetes mellitus have been of provenntakumari).
2013, Cardiological Societdietary composition for these patients. Genetic factors and the
lipid phenotype of the individual determine the way the
plasma lipid profiles change in these patients.5 Lifestyle
changes, including increased physical activity and dietary
modifications have, however, been the cornerstones of man-
agement of dyslipidemia in diabetes.6
Mahajan conducted a study on subjects with mild to
moderate hypertension and reported that yoga can play an
important role in risk modification for cardiovascular dis-
eases.7 Another study had reported a better lipid profile in
long and medium term mediators when compared to non-
meditators.8 In view of these observations, the present study
was undertaken to assess the effect of yoga practice on the
lipid profile in patients with type 2 diabetes mellitus (DM).y of India. All rights reserved.
Table 1 e Yoga practices specified for diabetic patients.
Asanas (body postures) 30e35 min
Suryanamaskaram (sun salutation) 5 min
Yoga Mudrasana (psychic union pose) 2 min
Vajrasana (thunderbolt pose) 2 min
Vakrasana (twisted pose) 2 min
Paschimottasana (seated forward bend) 2 min
Pavanamuktasana (wind relieving pose) 2 min
Sashankasana (hare pose) 2 min
Ushtrasana (camel pose) 2 min
Bhujangasan (cobra pose) 2 min
Dhanurasana (bow pose) 2 min
Arthakatichakrasana (lateral arc pose) 2 min
Parivatha trilokasanaan (revolved triangle pose) 2 min
Shavasana (corpse pose) 5 min
Pranayama (breathing exercises) 10 min
Ujjayi pranayama 5 repeats
Anuloma viloma 10e15 repeats
Alternate Kapalapathi pranayama 5 repeats
Suryabhedha pranayama 5 repeats
Meditation 15 min
Oneeone meditation 5 min
Breath counting meditation 5 min
Thought counting meditation 5 min
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2.1. Setting
Patients reporting to the out-patient department of Holistic
Medicine and in the Diabetic clinic, Medical College Trivan-
drum, Kerala, India, in the year 2005 were the participants of
this randomized parallel study. The Holistic Medicine
department aims at bringing lifestyle modifications in pa-
tients with non-communicable diseases and also offers reg-
ular yoga classes for all the patients in its care. The study was
conducted after the approval of the Ethics Committee of the
Medical faculty and all subjects volunteered for the trial.
2.2. Study sample
The guidelines of the National Diabetes Data Group and the
third set of the Adult Treatment Panel of the National
Cholesterol Education Program (NCEP ATP III) were used to
recruit one hundred patients with type 2 diabetes and dysli-
pidemia.9,10 Known diabetic patients who were on treatment
with sulphonylureas were included in the study. Patients who
are smokers, alcoholics, pregnant, on long-term steroids and
those with known retinopathy, nephropathy, coronary artery
disease and cerebrovascular diseases were excluded from the
study.
One hundred patients with type 2 DM attending the Dia-
betic clinic were randomized into control group of 27 males
and 23 females and experimental group of 24 males and 26
females. The experimental group was prescribed oral hypo-
glycemic drugs and in addition followed lifestyle modification
in the form of 1 h daily practice of yoga for a period of 3
months at the Holistic Medicine department. The control
group was prescribed oral hypoglycemic drugs only and did
not perform yogic exercises during this period.
2.3. Methodology
Detailed history of the patients including age, gender, and
disease history including duration and complications, treat-
ment details including drug, dosage and duration of treatment
were noted in the questionnaire. Bodyweight and height were
measured using standard protocols with participants wearing
light clothing without shoes. Body mass index (BMI) was
calculated.Waist and hip circumferencesweremeasured. The
patients were advised to come fasting overnight and 5 ml
blood samples were withdrawn from each patient under all
aseptic conditions and collected in plain bottles. The fasting
blood samples were analyzed for triglycerides (TG), total
cholesterol (TC) and high-density lipoproteinecholesterol
(HDLeC). Cholesterol were estimated by modified Roeschlav’s
method11 and Triacylglycerol by themethod ofWakomodified
by Mc Gowan et al.12 HDL cholesterol was assessed by phos-
photungstic acid method.13 LDL cholesterol was not sepa-
rately estimated but calculated from the formula: LDL
cholesterol ¼ Total cholesterol e [HDL cholesterol þ TG/5].
Yoga classes were conducted by an experienced yoga
teacher who chose the asanas in the package and adapted
their execution to the needs and abilities of the participants.The experimental group was taught a series of yoga postures
in groups of 25 patients each. They were instructed to practise
them daily for 1 h duration and were asked to record the
number of minutes they engaged in yoga per day. Yoga
treatment consisted of practice of 1) asanas (Body postures), 2)
pranayama (Breathing exercises) and 3) meditation tech-
niques (Table 1), to be practiced for 1 h duration. At the end of
2 weeks of supervised yogic training each subject was given
advice on ongoing medical treatment and was given a booklet
illustrating personalized yoga program to practice regularly at
home. All subjects were required to contact the Holistic
Medicine department once every month for follow up advice.
The control group was asked to report to Diabetic clinic every
month for their follow up after being given advice on ongoing
medical treatment at the start of the study. There were no
alterations made in the treatment and dietary habits of either
group during the study period. Both the groups were advised
to continue with their carbohydrate restricted fiber rich diet.
The BMI, W/H circumference and lipid profile of all the
participants weremeasured at the end of 3months. Data were
entered in Microsoft Excel and SPSS Version 12 was used for
analysis. Paired and unpaired t tests were employed to
compare measures. A p value of <0.05 as significant and a p
value of <0.01 was considered highly significant.3. Results
A total of 100 type 2 diabetic patients, 52males and 48 females
of mean age 45 years participated in the study. The average
duration of diabetes in the participants was 5e10 years. Both
the groups were similar in respect to mean age, sex, weight,
BMI,W/H ratio, glycemic control, Serum triglycerides and HDL
levels. The total cholesterol and LDL levels were, however,
significantly higher in the experimental group compared to
control group (Table 2).
Table 2 e Baseline characteristics of the participants.
Parameters Control group Study group
(Medication
only) n ¼ 50
(Medication þ
Yogic intervention)
n ¼ 50
Mean age (years) 44.46  10.98 45.51  7.98
Sex (M/F) 23 F, 27 M 26 F, 24 M
Wt (kg) 62.20  4.45 62.17  4.67
BMI (kg/m2) 23.2  2.14 22.9  2.15
W/H ratio 0.93 þ 0.07 0.94 þ 0.07
FBS (mg/dl) 181.57  66.25 155.86  60.53
PPBS (mg/dl) 265.31  74.70 240.31  79.42
Total cholesterol (mg/dl) 225.74  37.60 244.86  28.09*
Triglyceride (mg/dl) 172.74  52.55 151.89  43.08
LDL cholesterol (mg/dl) 126.11  30.41 144.74  28.46*
HDL cholesterol (mg/dl) 44.23  5.21 44.63  9.35
*p < 0.05.
Table 4 e Comparison of initial values of parameters and
follow up values of the control group.
Parameters n ¼ 50 Initial value
(mean  SD)
Follow up
(mean  SD)
WT (kg) 62.17  4.67 63.03  5.10*
BMI (kg/m2) 24.73  1.87 25.03  2.14
W/H ratio 0.93 þ 0.07 0.91 þ 0.05
Total cholesterol (mg/dl) 225.74  37.60 235.23  26.64
Triglycerides (mg/dl) 172.74  52.55 197.91  130.11
LDL cholesterol (mg/dl) 126.11  30.41 126.60  22.84
HDL cholesterol (mg/dl) 44.23  5.21 43.13  12.33
*p < 0.05.
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in a non-significant decrease in BMI from 25.12  1.54 to
23.59  1.38 kg/m2. A significant decrease in the weight from
62.20 4.45 to 59.60 4.65 kg andW/H ratio from 0.94þ 0.07 to
0.89 þ 0.07 was recorded.
There was a significant reduction in total cholesterol, tri-
glycerides and LDL cholesterol. Mean total cholesterol before
yoga was 244.86  28.09 mg% and was reduced to a mean of
219.56  32.02 mg%. Triglycerides showed a significant
reduction from 151.88  43.08 mg% to 130.11  28.82 mg%
while the LDL reduced from144.74 28.45 to 120.51 34.31mg
%. There was a non-significant elevation in HDL from
44.63  9.35 mg% to 47.15  8.17 mg % (Table 3).
After a period of 3 months the control group showed a
significant increase in body weight, non-significant increase
in BMI, total cholesterol, triglycerides and LDL and a decrease
in HDL (Table 4).4. Discussion
The present study was aimed at studying the effect of prac-
ticing yoga in patients with type 2 DM for 3 months. The
practice of yoga in these patients resulted in a decrease in BMI,
body weight, W/H ratio, total cholesterol, triglycerides and
LDL cholesterol and an increase in HDL.Table 3 e Comparison of pre-yoga and post-yoga values
in experimental group.
Parameters n ¼ 50 Pre-yoga
(mean  SD)
Post-yoga
(mean  SD)
WT(kg) 62.20  4.45 59.60  4.65*
BMI (kg/m2) 25.12  1.54 23.59  1.38
W/H ratio 0.94 þ 0.07 0.89 þ 0.07*
Total cholesterol (mg/dl) 244.86  28.09 219.54  32.02**
Triglycerides (mg/dl) 151.88  43.08 130.11  28.82*
LDL cholesterol (mg/dl) 144.74  28.45 120.51  34.31**
HDL cholesterol (mg/dl) 44.63  9.35 47.15  8.17
*p < 0.05, **p < 0.01.Improving glycemic control has not yet been shown to
prevent development ofmacro-vascular complications in type
2 DM. Alternately, carefully controlled treatment measures
with exercise, dietary modification and oral drugs can be ex-
pected to improve diabetic lipid disorder.14
The effect of exercise on blood lipid profiles has been
widely reported.15,16 Physical activity raises HDL levels and
decreases the concentration of very low-density lipoprotein
cholesterol and triglycerides.17 Physical activity and HDL
appear to be linked via HDL’s role in triglyceridemetabolism.18
It is, however, seen that diabetic patients usually cannot
sustain the levels of recommended physical activity for them
due to varied reasons like age, obesity, cardiovascular disease
and other complications. Compliance and motivation for
performing activity at 50e70% of maximum aerobic capacity
regularly is quite poor.19
Yoga has a beneficial effect on insulin kinetics and the lipid
profileresultingfromit.Adecrease inwaisthipratio inthisstudy
isconsistentwith that reportedbySahayetal,whoalso reported
an associated increase in lean bodymass and reduction in skin
fold thickness. Yoga helps in redistribution of body fat and
reduction in central obesity which leads to insulin resistance. A
decrease in insulin resistance, increase in insulin receptors and
sensitivity,shiftofpeak levelof insulinto leftwithnormalization
of insulin glucagon ratio was also reported.20
The dynamic stretching of the body during yoga asanas is
postulated to rejuvenate pancreatic cells, increase insulin
secretion and hence correct the impaired insulin secretion in
chronic diabetes.21
Various studies have reported physical, physiological,
psychological and endocrinological changes with the practice
of yoga. Manchanda and Narang found that after one year of
yoga therapy, patients with coronary artery disease (CAD)
showed significant reduction in serum total cholesterol, tri-
glycerides and LDL cholesterol. The patients showed a sig-
nificant reduction in the number of angina episodes and
required revascularization procedures less frequently. Angi-
ography after one year showed regression of lesions.22 The
practice of Raja yoga meditation was found to lower serum
cholesterol by Vyas,23 while Sahay20 and Bijlani24 noted that
yoga practice causes significant reduction in free fatty acids,
LDL, VLDL and an increase in HDL.
The beneficial effect of yoga in the management of
hyperlipidemia and obesity cannot just be attributed alone to
the simple excess calorie expenditure as there is no rapid
muscle activity and energy generation involved in yoga.
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cortisol which causes central obesity and insulin resistance.25
It increases gluconeogenesis and diminishes peripheral up-
take of glucose.26 Decreased glucose uptake and insulin
secretion can also occur due to stress induced release of
growth hormone and b endorphin.27 Elevated cortisol is also
linked to dyslipidemia, and higher blood pressure.28 Yoga has
been reported to lower levels of sympathetic hormones and
reduce cortisol. Pranayama reduces sympathetic tone, in-
creases parasympathetic activity and also helps an individual
reduce stress.8,29,30 Meditation also brings about a hypo-
metabolic state and reduces stress induced sympathetic over
activity.31 Better ability to overcome stress resulting in low-
ered cortisol levels can be cited as possible mechanism for
improvement in lipid profile in patients practicing yoga.
Dyslipidemia is usually associated with the abnormalities
in lipolysis; triglyceride metabolism and free fatty acid turn
over in a case of insulin resistance. Impaired lipoprotein lipase
and increased hepatic lipase activity is thought be a resulting
from insulin resistance in diabetes. Chronic exposure to
elevated free fatty acids have been associated with impaired
insulin secretion.32 The improvement in lipid profile with
practice of yoga could be due to increased hepatic lipase and
lipoprotein lipase. This would increase the uptake of tri-
glycerides by adipose tissue and affect the lipoprotein
metabolism.33
Yoga practice is also proved to affect mental balance of an
individual allaying apprehension, stress and bringing about
hormonal balance and feelings of well being. This sense of
well being is attributed to its ability to increase endogenous
melatonin secretion.34 This can explain the probability of
greater compliance with its practice even in long-term and its
use as an effective intervention in control of the disease.5. Conclusion
The present study has shown an efficacy of improving the
dyslipidemic state associated with diabetes. Yoga, being a
lifestyle incorporating exercise and stress management
training, targets the elevated lipid through integrated ap-
proaches resulting in improved lipid profiles, lower BMI, and
macro-vascular complications in diabetes.5.1. Strength of study
The yoga package was designed after extensive literature re-
view by yoga specialists and was a perfect combination of
asana and breathing exercises targeted at the disease under
study. Excellent compliance of study sample and there were
no drop outs. Experimental group patients voluntarily re-
ported to Holistic medicine department and were self moti-
vated for the practice of yoga. The control group was also
under constant surveillance by the Diabetic care clinic.5.2. Limitations of the study
Direct supervision of the patients was not possible for the
entire period of the study. Dietary data were not recorded.Long-term study was not possible due to threat of non-
compliance of the patients.Conflicts of interest
All authors have none to declare.r e f e r e n c e s
1. Taskinen MR. Diabetic dyslipidemia. Atheroscler Suppl.
2002;3(1):47e51.
2. Mooradian Arshag D. Dyslipidemia in type 2 diabetes
mellitus. Nat Clin Pract Endocrinol Metab. 2009;5:150e159.
3. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total
cholesterol concentrations and awareness, treatment, and
control of hypercholesterolemia among US adults: findings
from the National Health and Nutrition Examination Survey,
1999 to 2000. Circulation. 2003;107:2185e2189.
4. Imperatore G, Cadwell BL, Geiss L, et al. Thirty year trends in
cardiovascular risk factor levels among US adults with
diabetes: National Health and Nutrition Examination Surveys,
1971e2000. Am J Epidemiol. 2004;160:531e539.
5. Krauss RM. Dietary and genetic probes of atherogenic
dyslipidemia. Arterioscler Thromb Vasc Biol. 2005;25:
2265e2272.
6. Expert Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults. Executive summary of the third
report of the National cholesterol education program (NCEP)
expert Panel on detection, evaluation, and treatment of high
blood cholesterol in adults (Adult treatment Panel III). JAMA.
2001;285:2486e2497.
7. Mahajan AS, Reddy KS, Sachdeva U. Lipid profile of coronary
risk subjects following yogic lifestyle intervention. Indian
Heart J. 1999;51:37e40.
8. Damodaran A, Malathi A, Patil N, Shah N, Suryananshi,
Marathe S. Therapeutic potential of yoga practices in
modifying cardiovascular risk profile in middle aged men and
women. J Assoc Physicians India. 2002;50:633e640.
9. Vyas R, Dikshit N. Effect of meditation on respiratory system,
cardiovascular system and lipid profile. Ind J Physiol Pharmacol.
2002;46(4):487e491.
10. National Diabetes Data Group. Classification and diagnosis of
diabetes mellitus and other categories of glucose intolerance.
Diabetes. 1979;28:1039e1057.
11. Expert Panel on Detection, Evaluation and treatment of high
blood cholesterol in adults (Adult treatment Panel III). JAMA.
2001;285:2486e2497.
12. Mc GowanMW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-
coupled method for the colorimetric determination of serum
triglycerides. Clin Chem. 1983;29:538e542.
13. Trider P. Clinical chemistry. Ann Clin Biochem. 1969;6:24e27.
14. Burstein M, Scholnic HR, Morfin R. Rapid method for the
isolation of lipoproteins from human serum with polyanions.
J Lipid Res. 1970;11:583e595.
15. Pyorala k, Laakso M, Ustipa M. Diabetes and atherosclerosis;
an epidemiological view. Diabetes Metab Rev. 1987;3:463e524.
16. Szapary PO, Bloedon LT, Foster GD. Physical activity and its
effects on lipids. Curr Cardiol Rep. 2003;5:488e492.
17. Asikainen TM, Miilunpalo S, Kukkonen-Harjula K, et al.
Walking trials in postmenopausal women: effect of low doses
of exercise and exercise fractionization on coronary risk
factors. Scand J Med Sci Sports. 2003;13:284e292.
18. Clearfield Michael B. The national cholesterol education
program adult treatment Panel III guidelines. JAOA; 2003.
i n d i a n h e a r t j o u rn a l 6 5 ( 2 0 1 3 ) 1 2 7e1 3 1 13119. Thompson PD. What do muscles have to do with
lipoproteins? Circulation. 1990;81:1428e1430.
20. Skarfors ET, Wegener TA, Lithell H, Selinus I. Physical training
as treatment for Type 2 (non-insulin-dependent) diabetes in
elderly men. A Feasibility Study Over 2 Years. Diabetologia.
1987;30(12):930e933.
21. Sahay BK. Role of yoga in diabetes. J Assoc Physicians India.
2007;55:121e126.
22. Singh S, Malhotra V, Singh KP, Madhu SV, Tandon OP. Role of
yoga in modifying certain cardiovascular functions in Type 2
diabetic patients. J Assoc Physicians India. 2004;52:203.
23. Manchnada SC, Narang R, Reddy KS, Sachdev V. Retardation
of coronary atherosclerosi with yoga lifestyle intervention.
J Asso Physiocians in India. 2000;48:487e494.
24. Vyas R, Dikshit N. Effect of meditation on respiratory system,
cardiovascular system and lipid profile. Indian J Physio
Pharmacol. 2001;45(4):493e496.
25. Bijlani RL, Vempati RP, Yadav RK, et al. A brief but
comprehensive lifestyle education program based on yoga
reduces risk factors for cardiovascular disease and diabetes
mellitus. J Altern Complement Med. 2005;11(2):267e274.
26. Bjorntorp P. Metabolic implications of body fat distribution.
Diabetes Care. 1991;14:1132e1143.27. Chrousos GP, Gold PW. A healthy body in a healthy mind and
vice versa: the damaging power of uncontrollable stress. J Clin
Endocrinol Metab. 1998;83:1842e1845.
28. Giugliano D. Morphine, opioid peptides, and pancreatic islet
function. Diabetes Care. 1984;7:92e98.
29. Udupa K, Madanmohan, Ananda BB, Vijayalakshmi P,
Krishnamoorthy N. Effect of pranayama training on cardiac
function in normal young volunteers. Indian J Physiol
Pharmacol. 2003;47:27e33.
30. Raghuraj P, Ramakrishnan AG, Nagendra HR, Telles S. Effect
of two selected yogic breathing techniques on heart rate
variability. Indian J Physiol Pharmacol. 1998;42:467e472.
31. Sandeep B, Pandey US, Verma NS. Improvement in oxidative
status with yogic breathing in young healthy males. Indian J
Physiol Pharmacol. 2002;46:349e354.
32. Perez-De-Albeniz A, Holmes J. Meditation:concepts, effects
and uses in therapy. Int J Psychotherapy. 2000;5:49e58.
33. Shradha Bisht, Sisodia SS. Diabetes, dyslipidemia, antioxidant
and status of oxidative stress. IJRAP. 2010;1(1):33e42.
34. Harinath K, Malhotra AS, Pal K, et al. Effects of hatha yoga
and omkar meditation on cardiorespiratory performance,
psychological profile and melatonin secretion. J Altern
Complement Med. 2004;10(2):261e268.
